Sangamo Therapeutics Sees Shares Surge as FDA Grants Fast Track for Landmark Transplant Rejection Therapy
A Beacon of Hope: Reviva Pharmaceuticals' Brilaroxazine Achieves Pivotal Milestones in Schizophrenia Treatment
The Fibromyalgia Frontier: Why Tonix Pharmaceuticals Just Rocketed into the Spotlight
Alto Neuroscience's Breakthrough: Schizophrenia Drug ALTO-301 Rockets Towards Approval with FDA Fast Track!